Ruxolitinib cream 1.5% was safe and effective for the treatment of children and adolescents with a 35% or greater body surface areas affected by atopic dermatitis, according to a study.Ruxolitinib ...
Researchers studied genetically modified mice that lack NP2 itch-sensing neurons, to investigate the connection between itch, scratch, and inflammation.